QUISITIVE TECHNOLOGY SOLUTIONS, INC.

Profile

Company Names

QUISITIVE TECHNOLOGY SOLUTIONS, INC.

Addresses

161 BAY STREET, SUITE 2325, TORONTO, A6 M5J2S1

161 BAY STREET, SUITE 2325, TORONTO, A6 M5J 2S1

Phone Numbers

972-573-0995

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$503,151.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-11-17 
$357,086.00 
$357,086.00 
$0.00 
Equity 
1
2020-06-26 
$146,065.00 
$253,178.00 
$107,113.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LAURIE 
 
GOLDBERG 
DIRECTOR
DAVID 
 
GUEBERT 
DIRECTOR
VIJAY 
 
JOG 
DIRECTOR, EXECUTIVE OFFICER
MICHAEL 
 
MURPHY 
EXECUTIVE OFFICER
GLEICHEN RESOURCES LTD.   |  NEXUS ENERGYHOMES, INC.   |  TMG ENERGY CORP   |  DIAMOND FOODS INC   |  TOREX GOLD RESOURCES INC.   |  3D VISION SYSTEMS LLC   |  NATIONAL GENERAL HOLDINGS CORP.   |  HOLY MOUNTAIN BREWING CO   |  AMERICAN HOTEL INCOME PROPERTIES REIT INC.   |  STACKIQ, INC.   |  KINEX PHARMACEUTICALS, INC.   |  DISTRIBU.TD, INC.   |  TRANSEASTERN POWER TRUST   |  SUN CLINICAL LABORATORY, LLC - SERIES 4   |  SUN CLINICAL LABORATORY, LLC - SERIES 3   |  SUN CLINICAL LABORATORY, LLC - SERIES 1   |  SUN CLINICAL LABORATORY, LLC - SERIES 7   |  SUN CLINICAL LABORATORY, LLC - SERIES 5   |  SUN CLINICAL LABORATORY, LLC - SERIES 10   |  SUN CLINICAL LABORATORY, LLC - SERIES 8   |  SUN CLINICAL LABORATORY, LLC - SERIES 9   |  SUN CLINICAL LABORATORY, LLC - SERIES 14   |  PROCTORFREE, INC.   |  SUN CLINICAL LABORATORY, LLC - SERIES 15   |  ROSECLIFF VENTURE PARTNERS, LP   |  AHTOVATION, INC.   |  ADVANTAGE ADVISERS XANTHUS FUND, L.L.C.   |  AKONNI BIOSYSTEMS INC   |  SUN CLINICAL LABORATORY, LLC - SERIES 29   |  ALTERNATE HEALTH CORP.   |  ROSECLIFF VENTURE PARTNERS II, LP   |  ASSABET VALLEY BANCORP   |  AMPLE HILLS HOLDINGS, INC.   |  POST.BID.SHIP., INC.   |  PROPHET ADVANTAGE PARTNERS LP   |  ETHOS GOLD CORP.   |  TENEO PARTNERS, LP   |  ROSECLIFF CREDIT OPPORTUNITY FUND I, L.P.   |  TORTOISE, INC.   |  QUISITIVE TECHNOLOGY SOLUTIONS, INC.   |  PROSPECTOR METALS CORP.   |  BATTERY METALS STREAMING CORP.   |  ANTHEM SPORTS + ENTERTAINMENT INC.   |  MICROSHARE, INC.   |  ANOKIWAVE, INC.   |  ROSECLIFF FRONTIER TECHNOLOGIES FUND I, L.P.   |  AQUILA HARTLAND HOLDINGS, LLC   |  BOOSTLY, INC.   |  SOUTH PACIFIC METALS CORP.   |  ARA LABS INC.   |  NEXT GENERATION SPV 1 LLC   |  NEXT GENERATION SPV 2 LLC   |  NEXT GENERATION SPV 3 LLC   |  WPSL PRO, LLC   |  ROSECLIFF NEXT GENERATION LLC - SERIES RSAI ACCESSS-1   |  ROSECLIFF NEXT GENERATION LLC - SERIES P ACCESS   |  ROSECLIFF NEXT GENERATION LLC - SERIES CBIO ACCESS -1   |  ROSECLIFF NEXT GENERATION LLC - SERIES PVTR ACCESS
MICHAEL 
 
REINHART 
EXECUTIVE OFFICER, DIRECTOR
PHIL 
 
SORGEN 
DIRECTOR
PHILIP 
 
SORGEN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-17 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
EIGHT CAPITAL CORP.
EIGHT CAPITAL
NONE